J Orthopaed Surg Res (2021) 16(1):116
Over the past couple of years, several reviews have been published in academic journals by researchers at major universities in the U.S., Britain, and Poland
Higher doses reached that plateau later in the trial. In a 112-week step-down trial, participants maintained 21.9% loss on the top dose, 16.6% after stepping down to 5 mg, and 9.9% on placebo
beyond that trial and the halted Phase 2 lipodystrophy study, there are no completed human trials measuring body composition, strength, or long-term safety outcomes, so evidence for bodybuilding-related benefit claims remains preliminary and largely extrapolated from the hormone's known biology rather than from direct testing of CJC-1295
Many compounded tirzepatide formulations across different pharmacies include niacinamide or other stabilizing agents for exactly this reason